Skip to content

Dimension Vista CTNI Flex Reagent Cartridge

by Dade Behring, Inc. 510(k)

Active United States

510(k) K063756

Regulatory status

as of 29 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK063756 Date19 Mar 2007ClearedStatusActive

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Recalls

1 recall · FDA

    • Terminated Z-1671-2018 FDA Class II initiated 2 Jan 2018

    Concentrations for the level of biotin that does not interfere is not currently listed in the instruction for use for the Dimension Vista CTNI, Dimension Vista MMB, Dimension Sirolimus, ADVIA Centaur FOL, ADVIA Centaur aHBcM and the following IMMULITE assays, 3gAllergy Specific IgE, anti-HBc, BR-MA (CA15-3), CEA, Folic Acid, Gastrin, OM-MA (CA125), Thyroglobulin, and Vitamin B12, and these assays are susceptible to interference from biotin.

Specification

510(k)

510(k) Number
FDA Product Code
MMI
Device Class
Class II
Regulation
21 CFR Part 862.1215
Advisory Committee
Clinical Chemistry
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Dimension Vista CTNI Flex Reagent Cartridge is an immunoassay method for the quantitative measurement of cardiac troponin I, a biomarker for myocardial infarction. It employs a two-step latex agglutination assay with biotinylated antibody fragments to detect troponin I in human serum or plasma, enabling rapid and precise cardiac troponin I quantification.

This single-use reagent cartridge is designed for use with the Dimension Vista integrated chemistry system, requiring no additional sterilization. Supplied as a sterile, ready-to-use component, it is classified under FDA product code MMI (Immunoassay Method, Troponin Subunit) and adheres to Class II regulatory standards. Storage conditions and shelf life are specified in the accompanying documentation.

Other devices from Dade Behring, Inc.

See all devices from Dade Behring, Inc. →

Questions

AI-generated answers, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the Dimension Vista CTNI Flex Reagent Cartridge used for in clinical practice?

    The Dimension Vista CTNI Flex Reagent Cartridge is designed for the quantitative measurement of cardiac troponin I in human serum or plasma. Cardiac troponin I is a key biomarker used to diagnose myocardial infarction (heart attack), so this cartridge helps clinicians assess heart damage by providing rapid and precise results.

  • Is the Dimension Vista CTNI Flex Reagent Cartridge intended for single-use or can it be reused?

    The cartridge is explicitly labeled as a single-use component. It is supplied sterile and ready-to-use, eliminating the need for additional sterilization between uses. Reuse is not recommended or supported by the manufacturer.

  • What system does this reagent cartridge require for operation, and how is it supplied?

    The cartridge is designed exclusively for use with the Dimension Vista integrated chemistry system. It is supplied as a sterile, ready-to-use component, meaning no further preparation is needed before insertion into the system.

  • How should the Dimension Vista CTNI Flex Reagent Cartridge be stored, and what documentation covers its shelf life?

    Storage conditions and shelf life details are not explicitly listed in the provided data, but the manufacturer’s accompanying documentation (likely included with the product) specifies these requirements. Always refer to the official instructions for proper storage to maintain accuracy and reliability.

  • What regulatory pathway was followed for FDA clearance of this device, and what classification does it fall under?

    The cartridge received FDA 510(k) clearance under the Traditional pathway, classified as Substantially Equivalent (SESE). It falls under FDA product code MMI (Immunoassay Method, Troponin Subunit) and adheres to Class II regulatory standards, as indicated in the submission records.